The Hematology Unit provides a multidisciplinary and comprehensive approach to the treatment of hematological and oncological tumors, combining cutting-edge technology, innovative therapies, and a highly specialized team.
Our unit follows updated protocols in line with national and international clinical guidelines, rapidly incorporating the latest radiotherapy techniques while ensuring maximum patient safety.
Varian Edge HyperSight with high precision and integrated artificial intelligence
General Electric BigBore 64-slice planning CT
Adaptive radiotherapy and SGRT (Surface-Guided Radiotherapy)
4D control and respiratory gating for maximum precision in mobile tumors
Advanced dosimetric protocols with rigorous quality checks
Comprehensive treatment of hematological and oncological tumors
Radiotherapy combined with immunotherapy and targeted therapies
Prevention and management of toxicities
Multidisciplinary care with clinical hematology, medical oncology, radiophysics, and radiotherapy
Humanized care: supporting patients and families throughout the entire process
Pioneering professionals in advanced radiotherapy techniques
Close coordination between physicians, medical physicists, and radiotherapy technicians
Rapid initiation of treatments with no prolonged waiting lists
Constant innovation with the swift adoption of new techniques
Patient-centered care, with a human and compassionate approach
Treatments
Diagnostic Procedures:
Bone marrow aspiration
Bone marrow biopsy
Cytomorphology Unit:
Morphological study of bone marrow
Cytochemical staining
Flow Cytometry:
Diagnosis of malignant hematologic diseases
Clonality studies
Diagnosis of PNH (Paroxysmal Nocturnal Hemoglobinuria)
Minimal Residual Disease detection
Molecular Diagnosis:
PCR techniques
NGS techniques
Hemostasis and Thrombosis:
Diagnosis of platelet disorders
Study of congenital coagulopathies
Study of thrombophilia states
Erythropathology:
Diagnosis of thalassemias
Diagnosis of sickle cell disease
Diagnosis of anemias
Germ Cell Neoplasms and Clonal Hematopoiesis:
Diagnosis of germ cell neoplasms
Diagnosis of clonal hematopoiesis
Erythrocyte Disorders – Anemia Unit:
Deficiency anemias
Anemias of chronic disease
Hemolytic anemias
Congenital anemias
Heme group disorders
Leukocyte Disorders:
Neutropenia and agranulocytosis
Functional disorders
Hypereosinophilic syndrome
Bone Marrow Failure Syndromes:
Aplastic anemia
Pure red cell aplasia
Congenital dyserythropoietic anemias
Paroxysmal nocturnal hemoglobinuria
Acute Leukemias:
Acute Myeloid Leukemia (AML)
Acute Lymphoblastic Leukemia (ALL)
Chronic Leukemias:
Chronic Myeloid Leukemia (CML)
Chronic Lymphocytic Leukemia (CLL)
Chronic Myeloproliferative Syndromes:
Polycythemia Vera
Essential Thrombocythemia
Primary Myelofibrosis
Lymphomas:
Hodgkin’s Lymphoma
Non-Hodgkin’s Lymphomas
Monoclonal Gammopathies:
Monoclonal gammopathy of undetermined significance (MGUS)
Multiple Myeloma
Amyloidosis
Light chain deposition disease
Diseases of the Mononuclear Phagocyte System:
Langerhans cell histiocytosis
Erdheim-Chester disease
Rosai-Dorfman disease
Hemophagocytic lymphohistiocytosis
Histiocytic sarcoma
Coagulation Disorders:
Thrombocytopenia
Thrombocytosis
Platelet disorders
Congenital coagulopathies
Acquired coagulopathies
Primary hypercoagulable states
Secondary hypercoagulable states
Therapeutic monitoring of thromboembolic disease
Disseminated Intravascular Coagulation (DIC)
Thrombotic Thrombocytopenic Purpura (TTP)
Coagulation disorders in pregnancy
Hemostasis and Thrombosis:
Use of antiplatelets, anticoagulants, and thrombolytics
Treatment of von Willebrand disease with DDAVP
Immunotherapy for patients with inhibitors
Iron Overload Disorders (Hemochromatosis and Others):
Therapeutic phlebotomy
Oncohematology:
Administration of chemotherapy (oral, parenteral, and intrathecal)
Immunotherapy treatments
Supportive care treatments
Participation in Clinical Trials
Pide cita